Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2019

04.01.2019 | Gynecologic Oncology

Rates of regression of cervical dysplasia between initial biopsy and excisional procedure in routine clinical practice

verfasst von: Katrina Mark, Anja Frost, Heather Hussey, Micael Lopez-Acevedo, Anne E. Burke, Jill Edwardson, Opey Solaru, Patti Gravitt

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine rates and factors associated with regression of cervical intraepithelial neoplasia (CIN) 2 + between colposcopic biopsy and therapeutic excisional procedure in standard practice.

Methods

A retrospective chart review was performed for women undergoing a cervical excisional procedure for CIN 2 + at clinics at three academic institutions over a 3-year period. Cytology, histology, patient age and time-to-excision were analyzed to determine factors influencing rates of regression.

Results

Of 356 women undergoing excision for CIN 2 + on colposcopic biopsy, 91 (25.3%) of final pathology diagnoses displayed clinically significant regression. Age and time-to-excision were not associated with regression, but referral cytology and severity of initial biopsy histology were, with ASC-H (aOR 0.1, CI 0.03, 0.8) and CIN 3/AIS (aOR 0.4, CI 0.2, 0.7) being less likely to regress than less severe lesions.

Conclusions

Disease severity by referral cytology or diagnostic biopsy, as opposed to age or length of time-to-excision, is likely the most relevant factor in determination of regression for cervical intraepithelial neoplasia in women undergoing excisional treatment for biopsy-confirmed CIN2 +.
Literatur
3.
Zurück zum Zitat Tainio K, Athanasiou A, Tikkinen K, Aaltonen R, Cardenas J, Hernandes Glazer-Livson S, Jakobsson M, Joronen K, Kiviharju M, Louvanto K, Oksjoki S, Tahtinen R, Virtanen S, Nieminen P, Kyrfiou M, Kalliala I (2018) Clincial course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ 27(360):k499. https://doi.org/10.1136/bmj.k499 CrossRef Tainio K, Athanasiou A, Tikkinen K, Aaltonen R, Cardenas J, Hernandes Glazer-Livson S, Jakobsson M, Joronen K, Kiviharju M, Louvanto K, Oksjoki S, Tahtinen R, Virtanen S, Nieminen P, Kyrfiou M, Kalliala I (2018) Clincial course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ 27(360):k499. https://​doi.​org/​10.​1136/​bmj.​k499 CrossRef
4.
Zurück zum Zitat Melnikow J, Nuovo J, Willan A, Chan B, Howell L (1998) Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 92:727–735 (PMID:9764690)PubMed Melnikow J, Nuovo J, Willan A, Chan B, Howell L (1998) Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 92:727–735 (PMID:9764690)PubMed
8.
Zurück zum Zitat Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, Arbyn M, Bennett P, Paraskevaidis E (2016) Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ 28(354):i3633. https://doi.org/10.1136/bmj.i3633 CrossRef Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, Arbyn M, Bennett P, Paraskevaidis E (2016) Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ 28(354):i3633. https://​doi.​org/​10.​1136/​bmj.​i3633 CrossRef
9.
Zurück zum Zitat Nasiell K, Nasiell M, Vaclavinkova V (1983) Behavior of moderate cervical dysplasia during long-term follow up. Obstet Gynecol 61:609–614 (PMID:6835614)PubMed Nasiell K, Nasiell M, Vaclavinkova V (1983) Behavior of moderate cervical dysplasia during long-term follow up. Obstet Gynecol 61:609–614 (PMID:6835614)PubMed
12.
Zurück zum Zitat Holowaty P, Miller A, Rohan T, To T (1999) Natural history of dysplasia of the uterine cervix. J Nat Can Inst 91(3):252–258 (PMID:10037103)CrossRef Holowaty P, Miller A, Rohan T, To T (1999) Natural history of dysplasia of the uterine cervix. J Nat Can Inst 91(3):252–258 (PMID:10037103)CrossRef
13.
Zurück zum Zitat Dalla Palma P, Giorgi Rossi P, Collina G, Buccoliero AM, Ghiringhello B, Gilioli E, Onnis GL, Aldovini D, Galanti G, Casadei G, Aldi M, Gomes VV, Giubilato P, Ronco G, NTCC Pathology Group (2009) The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study. Am J Clin Pathol 132(1):125–132. https://doi.org/10.1309/ajcpbrk7d1yiuwfp CrossRefPubMed Dalla Palma P, Giorgi Rossi P, Collina G, Buccoliero AM, Ghiringhello B, Gilioli E, Onnis GL, Aldovini D, Galanti G, Casadei G, Aldi M, Gomes VV, Giubilato P, Ronco G, NTCC Pathology Group (2009) The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study. Am J Clin Pathol 132(1):125–132. https://​doi.​org/​10.​1309/​ajcpbrk7d1yiuwfp​ CrossRefPubMed
14.
Zurück zum Zitat Ismail S, Colclough A, Dinnen J, Eakins D, Evans DM, Gradwell E, O’Sullivan JP, SUmmerell JM, Newcombe RG (1989) Observer variation in histopathological diagnosis and grading cervical intraepithelial neoplasia. BMJ 298:707–710 (PMID:2496816)CrossRefPubMedPubMedCentral Ismail S, Colclough A, Dinnen J, Eakins D, Evans DM, Gradwell E, O’Sullivan JP, SUmmerell JM, Newcombe RG (1989) Observer variation in histopathological diagnosis and grading cervical intraepithelial neoplasia. BMJ 298:707–710 (PMID:2496816)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Carreon J, Sherman M, Guillen D, Solomon D, Herrero R, Jeronimo J, Wacholder S, Rodriguez AC, Morales J, Hutchinson M, Burk RD, Schiffman M (2007) CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population based cervical samples. Int J Gynecol Pathol 26:441–446. https://doi.org/10.1097/pgp.0b013e31805152ab CrossRefPubMed Carreon J, Sherman M, Guillen D, Solomon D, Herrero R, Jeronimo J, Wacholder S, Rodriguez AC, Morales J, Hutchinson M, Burk RD, Schiffman M (2007) CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population based cervical samples. Int J Gynecol Pathol 26:441–446. https://​doi.​org/​10.​1097/​pgp.​0b013e31805152ab​ CrossRefPubMed
18.
Zurück zum Zitat Rader JS, Sill MW, Beume JH, Lankes HA, Benbrook DM, Garcia F, Trinble C, Tate Thigpen J, Lieberman R, Zuna RE, Leath CA, Spirtos NM, Byron J, Thaker PH, Lele S, Alberts D (2017) A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: the potential predictive value of VEGF serum levels: an NRG oncology/gynecologic oncology group study. Gynecol Oncol 145(2):291–297. https://doi.org/10.1016/j.ygyno.2017.02.040 CrossRefPubMedPubMedCentral Rader JS, Sill MW, Beume JH, Lankes HA, Benbrook DM, Garcia F, Trinble C, Tate Thigpen J, Lieberman R, Zuna RE, Leath CA, Spirtos NM, Byron J, Thaker PH, Lele S, Alberts D (2017) A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: the potential predictive value of VEGF serum levels: an NRG oncology/gynecologic oncology group study. Gynecol Oncol 145(2):291–297. https://​doi.​org/​10.​1016/​j.​ygyno.​2017.​02.​040 CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Massad L, Einstein M, Huh W, Katki H, Kinney W, Schiffman M, Solomon D, Wentzensen N, Lawson H, for the 2012 ASCCP consensus guidelines conference (2012) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tact Dis 17:S1–S27. https://doi.org/10.1097/LGT.0b013e318287d329 CrossRef Massad L, Einstein M, Huh W, Katki H, Kinney W, Schiffman M, Solomon D, Wentzensen N, Lawson H, for the 2012 ASCCP consensus guidelines conference (2012) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tact Dis 17:S1–S27. https://​doi.​org/​10.​1097/​LGT.​0b013e318287d329​ CrossRef
20.
22.
Zurück zum Zitat Darragh T, Colgan T, Cox J, Heller D, Henry M, Luff R, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC, Members of the LAST Project Work Groups (2012) The lower anogenital squamous terminology standardization project for HPV-associated pathologists and the american society for colposcopy and cervical pathology. J Low Genit Tract Dis 16:205–242. https://doi.org/10.1097/lgt.0b013e31825c31dd CrossRefPubMed Darragh T, Colgan T, Cox J, Heller D, Henry M, Luff R, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC, Members of the LAST Project Work Groups (2012) The lower anogenital squamous terminology standardization project for HPV-associated pathologists and the american society for colposcopy and cervical pathology. J Low Genit Tract Dis 16:205–242. https://​doi.​org/​10.​1097/​lgt.​0b013e31825c31dd​ CrossRefPubMed
27.
Metadaten
Titel
Rates of regression of cervical dysplasia between initial biopsy and excisional procedure in routine clinical practice
verfasst von
Katrina Mark
Anja Frost
Heather Hussey
Micael Lopez-Acevedo
Anne E. Burke
Jill Edwardson
Opey Solaru
Patti Gravitt
Publikationsdatum
04.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2019
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-018-5026-8

Weitere Artikel der Ausgabe 3/2019

Archives of Gynecology and Obstetrics 3/2019 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.